Yttrium-90 glass microspheres radioembolization (RE) for biliary tract cancer: a large single-center experience

Is there a role for Ytrrium-90 in the treatment of unresectable and metastatic intrahepatic cholangiocarcinoma?

(2018) Tamer M. Shaker et al.   AMERICAN JOURNAL OF SURGERY

A MAA-based dosimetric study in patients with intrahepatic cholangiocarcinoma treated with a combination of chemotherapy and 90Y-loaded glass microsphere selective internal radiation therapy

(2018) Vincent Manceau et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Improving patient selection for selective internal radiation therapy of intra-hepatic cholangiocarcinoma: A meta-regression study

(2017) Alessandro Cucchetti et al.   LIVER INTERNATIONAL

Yttrium-90 radioembolization for unresectable/recurrent intrahepatic cholangiocarcinoma: a survival, efficacy and safety study

(2016) Cristina Mosconi et al.   BRITISH JOURNAL OF CANCER

Comparison of Choi criteria and Response Evaluation Criteria in Solid Tumors (RECIST) for intrahepatic cholangiocarcinoma treated with glass-microspheres Yttrium-90 selective internal radiation therapy (SIRT)

(2016) Luc Beuzit et al.   EUROPEAN JOURNAL OF RADIOLOGY

Resin-based Yttrium-90 microspheres for unresectable and failed first-line chemotherapy intrahepatic cholangiocarcinoma: preliminary results

(2016) Zhongzhi Jia et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Radioembolization with 90Y resin microspheres for intrahepatic cholangiocellular carcinoma: prognostic factors

(2015) Cigdem Soydal et al.   ANNALS OF NUCLEAR MEDICINE

Intra-arterial Yttrium-90 Radioembolization Combined with Systemic Chemotherapy is a Promising Method for Downstaging Unresectable Huge Intrahepatic Cholangiocarcinoma to Surgical Treatment

(2015) M. Rayar et al.   ANNALS OF SURGICAL ONCOLOGY

The Impact of Surgical Margin Status on Long-Term Outcome After Resection for Intrahepatic Cholangiocarcinoma

(2015) Gaya Spolverato et al.   ANNALS OF SURGICAL ONCOLOGY

Glass Microspheres 90Y Selective Internal Radiation Therapy and Chemotherapy as First-Line Treatment of Intrahepatic Cholangiocarcinoma

(2015) Julien Edeline et al.   CLINICAL NUCLEAR MEDICINE

Clinical impact of 99mTc-MAA SPECT/CT-based dosimetry in the radioembolization of liver malignancies with 90Y-loaded microspheres

(2015) Etienne Garin et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Gemcitabine and Oxaliplatin, but Not Sorafenib or Paclitaxel, Have a Synergistic Effect with Yttrium-90 in Reducing Hepatocellular Carcinoma and Cholangiocarcinoma Cell Line Viability

(2015) Julien Edeline et al.   JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY

Change in total lesion glycolysis and clinical outcome after 90Y radioembolization in intrahepatic cholangiocarcinoma

(2015) Luca Filippi et al.   NUCLEAR MEDICINE AND BIOLOGY

Modified Response Evaluation Criteria in Solid Tumors and European Association for the Study of the Liver Criteria Using Delayed-Phase Imaging at an Early Time Point Predict Survival in Patients with Unresectable Intrahepatic Cholangiocarcinoma following Yttrium-90 Radioembolization

(2014) Juan C. Camacho et al.   JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY

Cholangiocarcinoma

(2014) Nataliya Razumilava et al.   LANCET

Selective internal radiotherapy (SIRT) versus transarterial chemoembolization (TACE) for the treatment of intrahepatic cholangiocellular carcinoma (CCC): study protocol for a randomized controlled trial

(2014) Roman Kloeckner et al.   Trials

Cisplatin and gemcitabine for advanced biliary tract cancer: a meta-analysis of two randomised trials

(2013) J. W. Valle et al.   ANNALS OF ONCOLOGY

Boosted selective internal radiation therapy with 90Y-loaded glass microspheres (B-SIRT) for hepatocellular carcinoma patients: a new personalized promising concept

(2013) E. Garin et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Yttrium-90 Radioembolization for Intrahepatic Cholangiocarcinoma: Safety, Response, and Survival Analysis

(2013) Samdeep Mouli et al.   JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY

Influence of Surgical Margins on Outcome in Patients With Intrahepatic Cholangiocarcinoma

(2011) Olivier Farges et al.   ANNALS OF SURGERY

Transarterial Hepatic Yttrium-90 Radioembolization in Patients with Unresectable Intrahepatic Cholangiocarcinoma: Factors Associated with Prolonged Survival

(2011) Ralf-T. Hoffmann et al.   CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY

Radioembolisation of hepatocellular carcinoma patients using 90Y-labelled microspheres: towards a diffusion of the technique?

(2011) Etienne Garin   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Research Reporting Standards for Radioembolization of Hepatic Malignancies

(2011) Riad Salem et al.   JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY

Effectiveness of quantitative MAA SPECT/CT for the definition of vascularized hepatic volume and dosimetric approach

(2011) Etienne Garin et al.   NUCLEAR MEDICINE COMMUNICATIONS

Gemcitabine in the chemoradiotherapy for locally advanced pancreatic cancer: A meta-analysis

(2011) Chang-Peng Zhu et al.   RADIOTHERAPY AND ONCOLOGY

Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan

(2010) T Okusaka et al.   BRITISH JOURNAL OF CANCER

Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer

(2010) Juan Valle et al.   NEW ENGLAND JOURNAL OF MEDICINE

Yttrium-90 Radiotherapy for Unresectable Intrahepatic Cholangiocarcinoma: A Preliminary Assessment of This Novel Treatment Option

(2009) Akshat Saxena et al.   ANNALS OF SURGICAL ONCOLOGY

Burden of Digestive Diseases in the United States Part III: Liver, Biliary Tract, and Pancreas

(2009) James E. Everhart et al.   GASTROENTEROLOGY